Apyx Medical Past Earnings Performance

Past criteria checks 0/6

Apyx Medical's earnings have been declining at an average annual rate of -5.4%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 20.1% per year.

Key information

-5.4%

Earnings growth rate

-4.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate20.1%
Return on equity-70.0%
Net Margin-35.7%
Next Earnings Update09 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Apyx Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:BOV Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2352-19495
30 Sep 2350-15485
30 Jun 2347-16475
31 Mar 2344-21475
31 Dec 2245-23485
30 Sep 2249-19484
30 Jun 2251-18484
31 Mar 2252-16474
31 Dec 2149-15444
30 Sep 2143-15404
30 Jun 2138-14374
31 Mar 2131-15344
31 Dec 2028-12344
30 Sep 2025-16344
30 Jun 2025-16354
31 Mar 2028-16364
31 Dec 1928-20354
30 Sep 1926-18343
30 Jun 1922-15293
31 Mar 1919-14263
31 Dec 1817-11223
30 Sep 1814-10182
30 Jun 1813-12172
31 Mar 185-15172
31 Dec 1710-14172
30 Sep 17-12-19151
30 Jun 17-4-17151
31 Mar 1737-4203
31 Dec 169-12151
30 Sep 1635-5183
30 Jun 1633-5182
31 Mar 1631-6182
31 Dec 15308172
30 Sep 15294172
30 Jun 15283162
31 Mar 15274162
31 Dec 1428-18131
30 Sep 1426-18141
30 Jun 1425-15111
31 Mar 1424-16111
31 Dec 1324-7121
30 Sep 1324-2101
30 Jun 1325-1111

Quality Earnings: BOV is currently unprofitable.

Growing Profit Margin: BOV is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BOV is unprofitable, and losses have increased over the past 5 years at a rate of 5.4% per year.

Accelerating Growth: Unable to compare BOV's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BOV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: BOV has a negative Return on Equity (-70.02%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.